Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B-Reference-Cited by-同舟云学术

Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B

Published:2013-10-18 Issue:21 Volume:56 Page:8834-8848
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kale Manoj G.,Raichurkar Anandkumar,P Shahul Hameed,Waterson David,McKinney David¹,Manjunatha M. R.,Kranthi Usha,Koushik Krishna,Jena Lalit kumar,Shinde Vikas,Rudrapatna Suresh,Barde Shubhada,Humnabadkar Vaishali,Madhavapeddi Prashanti,Basavarajappa Halesha,Ghosh Anirban,Ramya VK,Guptha Supreeth,Sharma Sreevalli,Vachaspati Prakash,Kumar K.N. Mahesh,Giridhar Jayashree,Reddy Jitendar,Panduga Vijender,Ganguly Samit,Ahuja Vijaykamal,Gaonkar Sheshagiri,Kumar C. N. Naveen,Ogg Derek²,Tucker Julie A.²,Boriack-Sjodin P. Ann³,de Sousa Sunita M.,Sambandamurthy Vasan K.,Ghorpade Sandeep R.

Affiliation:

1. Chemistry, Infection iMed, AstraZeneca, Waltham, Massachusetts 02451, United States

2. Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield SK10 4TF, United Kingdom

3. Biosciences, Infection iMed, AstraZeneca, Waltham, Massachusetts 02451, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm401268f

Reference32 articles.

1. World Health Organization. Global Tuberculosis Control; WHO 2011 Report on Tuberculosis.http://www.who.int/mediacentre/news/releases/2011/tb_20111011/en/index.html

2. World Health Organization. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB); WHO 2010 Global Report on Surveillance and Response.

3. Rising to the challenge: new therapies for tuberculosis

4. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

5. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of novel Thiazolo[5,4-b]pyridine derivatives as potent and selective EGFR-TK inhibitors targeting resistance Mutations in non-small cell lung cancer;European Journal of Medicinal Chemistry;2024-10

2. Revealing the Interaction Mechanism between Mycobacterium tuberculosis GyrB and Novobiocin, SPR719 through Binding Thermodynamics and Dissociation Kinetics Analysis;International Journal of Molecular Sciences;2024-03-28

3. Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms;Molecules;2023-12-15

4. Elucidating specific interactions for designing novel pyrrolamide derivatives as potential GyrB inhibitors based on ab initio fragment molecular orbital calculations;Journal of Biomolecular Structure and Dynamics;2023-12-08

5. Sabinene: A New Green Solvent Used in the Synthesis of Thiazolo[5,4-b]pyridines by Thermal or Microwave Activation;Molecules;2023-10-03